Stock Events

Stock Events

4 SC

€2.98

5

+€0+0% Wednesday 12:41

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

19OctExpected

Q1 2016

Q2 2016

Q3 2021

Q1 2022

Q1 2023

Q2 2023

Q3 2023

-0.88

-0.85

-0.81

-0.77

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VSC.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Merck & Co., Inc. is a global healthcare company that operates in the pharmaceutical sector, directly competing with 4SC in the development and marketing of cancer treatments and therapies.

Bristol-Myers Squibb

Bristol-Myers Squibb Company is involved in the discovery, development, and delivery of medicines related to cancer, competing with 4SC in the oncology segment.

Pfizer Inc. is a research-based global biopharmaceutical company with a strong emphasis on oncology, making it a direct competitor to 4SC in cancer research and drug development.

Novartis AG focuses on patented medicines, including those for cancer treatment, positioning it as a competitor to 4SC in the oncology pharmaceuticals market.

Roche Holding AG specializes in biotechnology and pharmaceuticals, with a significant portion of its portfolio dedicated to oncology, competing with 4SC in cancer treatment innovations.

AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong focus on oncology, making it a competitor to 4SC in the development of cancer therapies.

Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that develops and markets medicines in areas including oncology, competing with 4SC in the cancer treatment market.

Amgen Inc. is a biotechnology company focused on human therapeutics, with a significant presence in oncology, competing with 4SC in the development of cancer treatments.

Johnson & Johnson

Johnson & Johnson is a diversified healthcare company with pharmaceutical products targeting various diseases, including cancer, making it a competitor to 4SC in the oncology market.

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for treating serious medical conditions, including cancer, positioning it as a competitor to 4SC in the field of oncology.

About

4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.

Show more...

CEO

Dr. Jason Loveridge B.Sc., B.Sc, Ph.D., FRSM

Employees

33

Country

DE

ISIN

DE000A3E5C40

WKN

000A3E5C4

Listings

0 Comments

Share your thoughts

FAQ

What is 4 SC stock price today?▼

The current price of VSC.XETRA is €2.98 EUR — it has increased by +0% in the past 24 hours. Watch 4 SC stock price performance more closely on the chart.

What is 4 SC stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange 4 SC stocks are traded under the ticker VSC.XETRA.

How many employees does 4 SC have?▼

As of April 07, 2026, the company has 33 employees.

In which sector is 4 SC located?▼

4 SC operates in the Healthcare sector.

When did 4 SC complete a stock split?▼

4 SC has not had any recent stock splits.

Where is 4 SC headquartered?▼

4 SC is headquartered in Planegg, DE.